OMDA

Omada Health, Inc. Common Stock

OMDA

Market cap $1.4B

Overview Fund Activity

24.28 USD

+0.56

2.36%

At close Updated Sep 5, 4:00 PM EDT

Pre-market

After hours

23.67

-0.61

2.51%

1 day

2.36%

5 days

1.68%

1 month

40.1%

3 months

5.57%

6 months

5.57%

Year to date

5.57%

1 year

5.57%

5 years

5.57%

10 years

5.57%

About: Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.

Employees: 859

Healthcare Health Information Services

0

Funds holding %

of 7,456 funds

0

Analysts bullish %

of 8 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

46.76% more ownership

Funds ownership: 0% [Q1] → 46.76% (+46.76%) [Q2]

See Fund Rankings

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$20

-18% downside

Avg. target

$25

1% upside

High target

$29

19% upside

8 analyst ratings

7 positive

88%

1 neutral

13%

0 negative

0%

Baird Vikram Kesavabhotla	$24	Neutral Initiated	5 Sep 2025
Canaccord Genuity Richard Close	$28	Buy Maintained	8 Aug 2025
Barclays Saket Kalia	$24	Overweight Maintained	8 Aug 2025
Needham Ryan MacDonald	$24	Buy Maintained	8 Aug 2025
Evercore ISI Group	$23	Outperform Maintained	9 Jul 2025
JP Morgan Destiny Jackson	$20	Overweight Initiated	1 Jul 2025
Morgan Stanley Craig Hettenbach	$25	Overweight Initiated	1 Jul 2025
Goldman Sachs David Roman	$29	Buy Initiated	1 Jul 2025

See Analyst Rankings

Financial journalist opinion

New Research from Omada Health Demonstrates Significant Cost Savings of Virtual Physical Therapy

SAN FRANCISCO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, released new data¹ demonstrating that patients who used Omada's virtual physical therapy (PT) program to address musculoskeletal (MSK) conditions, Omada for Joint & Muscle Health, had lower utilization of total medical care and reduced MSK-related costs and encounters on average at 6 and 12 months compared to patients who used in-person PT (IP-PT). This study is believed to be one of the first peer-reviewed healthcare claims analyses to compare costs and utilization of virtual PT (V-PT) and IP-PT in treating MSK conditions while also accounting for the cost of the virtual program itself.

New Research from Omada Health Demonstrates Significant Cost Savings of Virtual Physical Therapy

Omada Health to Participate in Upcoming Investor Conference

SAN FRANCISCO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference, taking place in New York, including a fireside chat on Tuesday, September 9, 2025, at 5:35 pm ET. The webcast will be available online at https://investors.omadahealth.com/news-events/events.

Omada Health to Participate in Upcoming Investor Conference

Omada Health beats on revenue in first earnings report since IPO

Omada Health reported quarterly results for the first time since its IPO in June. Omada's revenue increased 49% in its second quarter to $61 million.

Omada Health beats on revenue in first earnings report since IPO

Omada Health Reports Second Quarter 2025 Results

Revenue of $ 61 million, up 49% 52% Member Growth and Significant Progress Toward Profitability SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Omada Health, Inc. (Nasdaq: OMDA), the virtual between-visit healthcare provider, today reported financial results for the second quarter ended June 30, 2025. 2025 Second Quarter Highlights Total Members of 752,000, up 52% compared to the second quarter of 2024 Revenue of $61 million, up 49% compared to the second quarter of 2024 GLP-1 Companion Success, with strong growth in members being supported by Omada's GLP-1 companion programs - now available through two of the largest pharmacy benefit managers in the United States Omada Horizon Day: In May, Omada announced a new AI-agent, OmadaSpark, designed to deliver real-time motivational interviewing and nutrition education to members “I'm proud of our second quarter results, with 49% year-over-year revenue growth, strong margin improvements, and continued progress toward profitability,” said Sean Duffy, Co-founder and CEO of Omada Health.

Omada Health Reports Second Quarter 2025 Results

Omada Health: Long Growth Runway Ahead

I rate Omada Health a buy due to its strong clinical validation, strategic partnerships, and vast untapped market opportunity. OMDA's clinical outcomes, backed by 29 peer-reviewed studies, provide a true moat and credibility with sophisticated buyers like employers and health plans. Strategic partnerships with Cigna and CVS enable rapid scale, lower customer acquisition costs, and improve revenue visibility, accelerating OMDA's growth trajectory.

Omada Health: Long Growth Runway Ahead

Omada Health to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its second quarter 2025 results on Thursday, August 7, 2025, after market close, and host a conference call to review the results at 4:30 pm ET the same day. Conference Call Details Those participating in the conference call can pre-register using the following link: https://register-conf.media-server.com/register/BIce129368a015484a8f39659a48a1631e.

Omada Health to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

Omada Health's Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks

SAN FRANCISCO, June 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, released new data1 demonstrating that Omada's GLP-1 companion program significantly improved persistence rates for GLP-1 medications. Evidence suggests that persistence on a GLP-1 is associated with greater weight loss.2 Omada's analysis found that those who persisted with their GLP-1 medication achieved weight loss results similar to what has been found in controlled research settings.1 Despite a growing body of evidence supporting vast clinical benefits of GLP-1s,3 while results vary widely, one study showed that one-third of people stopped taking their GLP-1 in the first month, and less than half stayed on for more than 12 weeks.4 These data suggest that in the real world, factors like non-persistent medication use mean that many who use GLP-1s for weight management may not see the results reflected in clinical trials.

Omada Health's Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks

Omada Health: Helping Patients, Investors As Well?

Omada's IPO impresses with rapid revenue growth and a unique approach to chronic disease management, but the company remains unprofitable. Valuation is stretched at 5-6x sales, especially given continued operating losses and the need to prove sustainable growth. Key risks, other than losses, include reliance on few PBMs, potential engagement/churn issues, and privacy concerns, making the outlook uncertain.

Omada Health: Helping Patients, Investors As Well?

Omada Health IPO signals healthier market, avoids ‘down-round' trend

The IPO market is starting to feel healthier.

Omada Health IPO signals healthier market, avoids ‘down-round' trend

Business Insider

Diabetes startup Omada Health finally went public after 14 years. Here's who made bank.

Omada Health just became the second digital health company to IPO this year. The chronic care company saw its shares jump Friday morning by over 38% above its initial price.

Diabetes startup Omada Health finally went public after 14 years. Here's who made bank.

See News Rankings

Charts implemented using Lightweight Charts™